Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Up 0.7% – What’s Next?
by Scott Moore · The Cerbat GemPeak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report)’s stock price rose 0.7% on Tuesday . The company traded as high as $2.84 and last traded at $2.84. Approximately 429 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 9,053 shares. The stock had previously closed at $2.82.
Peak Pharmaceuticals Stock Performance
The stock’s 50-day moving average is $1.64 and its 200-day moving average is $1.26.
Peak Pharmaceuticals Company Profile
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Featured Articles
- Five stocks we like better than Peak Pharmaceuticals
- Do not delete, read immediately
- How Long Will $1M Last in Retirement?
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough